Aurobindo Pharma Quarterly Results for Trading Insights
AUROPHARMA • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹848 Cr
QSept 2025
Aurobindo Pharma Quarterly Results Key Highlights
- Revenue of ₹8,359 Cr in Sept 2025 (-1.8% vs Mar 2025, +7.4% vs Sept 2024)
- Net Profit of ₹848 Cr in Sept 2025 (-6.1% vs Mar 2025, +3.8% vs Sept 2024)
- EBITDA of ₹1,752 Cr in Sept 2025 (-7.5% vs Mar 2025)
- Operating Margin of 20.0% in Sept 2025 (-1.0pp vs Mar 2025)
- Earnings Per Share of ₹14.61 in Sept 2025 (-6.1% vs Mar 2025)
Aurobindo Pharma Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | Sept 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 8,359 | 8,516 | 7,899 | 8,793 | 7,783 | -1.8% | 7.4% |
| Net Profit (₹ Cr) | 848 | 903 | 824 | 910 | 817 | - | - |
| EBITDA (₹ Cr) | 1,752 | 1,894 | 1,634 | 1,855 | 1,553 | - | - |
| EPS (₹) | 14.61 | 15.56 | 14.20 | 15.67 | 14.00 | - | - |
| Operating Margin (%) | 20.0% | 21.0% | 20.0% | 19.0% | 19.0% | - | - |
Aurobindo Pharma Share Price Trend Around Quarterly Results
Visualize Aurobindo Pharma's 1-year price movement across quarterly results — ideal for logging trades in Aurobindo Pharma share price
chart using Tickjournal. All values in ₹.
Related Pages for Aurobindo Pharma
Additional stock information and data for AUROPHARMA
Revenue Trend (₹ Cr)
Dec 2025
8,793
Jun 2025
7,899
Mar 2025
8,516
Sept 2025
8,359
Net Profit Trend (₹ Cr)
Dec 2025
910
Jun 2025
824
Mar 2025
903
Sept 2025
848
Operating Margin Trend (%)
Dec 2025
19.0%
Jun 2025
20.0%
Mar 2025
21.0%
Sept 2025
20.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Aurobindo Pharma quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹438,094.57 Cr | 1825.3 | 14,875 | 3,125 | +10.8% | - | 21.0% | 140.4 |
|
Divis Laboratories
Sept 2025 |
₹167,616.86 Cr | 6282.0 | 2,860 | 689 | +7.1% | - | 24.1% | 241.9 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹148,025.88 Cr | 4446.0 | 3,219 | 591 | +11.3% | - | 18.4% | 253.5 |
|
Dr Reddys Laborator…
Sept 2025 |
₹110,630.25 Cr | 1319.0 | 9,135 | 1,337 | +1.1% | - | 14.6% | 81.5 |
|
Cipla
Sept 2025 |
₹107,029.80 Cr | 1324.3 | 7,716 | 1,353 | +12.0% | - | 17.5% | 79.2 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores